Skip to Content

Pfizer and Allergan to Merge in $155 Billion Inversion Deal
Merger creates a drug giant.
Antonio Regalado, Senior Editor, Biomedicine

The Climate Change Pledges Are In. Will They Fix Anything?
The clearest explanation that I’ve seen so far on the likely impact of the emissions reductions agreed to by countries at next week’s meeting on climate change in Paris.
David Rotman, Editor

The Pfizer-Allergan Merger Is a Disgrace
Pfizer has benefited enormously from taxpayer-funded research via the National Institutes of Health and the National Science Foundation. That wasn’t enough to convince management to remain a U.S.-domiciled taxpayer itself, however, writes John Cassidy of the New Yorker.
Nanette Byrnes, Senior Editor, Business Reports

It’s Time to Give Up on the Ideal of Perfect Privacy Online
We should let go of the idea of defending privacy against digital technology and instead focus on establishing the right to obscurity, which is more achievable, argue a professor of law and a professor of philosophy.
Tom Simonite, San Francisco Bureau Chief

Why Brazil’s New Pledges on Carbon Emissions Fall Short
On the eve of the Paris climate talks, a Brazilian political scientist discusses the crucial role her country will play.
Brian Bergstein, Executive Editor

Digitizing the Dead
“The Mormon mission to save souls—and Saskatchewan’s public archives”
Will Knight, Senior Editor, AI

Losing Religion through Twitter
A “prized daughter of the Westboro Baptist Church” broadcasts her questions about faith via social media.
—Will Knight

Quiz: The Pieces Everything Is Made Of
Let’s simplify this place—a quiz based on the thousand most common words used in English.
—J. Juniper Friedman, Associate Web Producer

Keep Reading

Most Popular

Rendering of Waterfront Toronto project
Rendering of Waterfront Toronto project

Toronto wants to kill the smart city forever

The city wants to get right what Sidewalk Labs got so wrong.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

images created by Google Imagen
images created by Google Imagen

The dark secret behind those cute AI-generated animal images

Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.